Perturbation of TSG101 protein affects cell cycle progression

Cancer Research

Volumn 58, Issue 13, 1998, Pages 2699-2702

  Zhong, Qing ^a   Chen, Yumay ^a   Jones, Diane ^a   Lee, Wen Hwa ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN;

ARTICLE; CANCER SUSCEPTIBILITY; CELL CYCLE; CELLULAR DISTRIBUTION; CYTOPLASM; GENE DELETION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MICROINJECTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANTIBODIES, MONOCLONAL; CELL DEATH; CELL NUCLEUS; CYTOPLASM; DNA-BINDING PROTEINS; G1 PHASE; HUMANS; NEOPLASM PROTEINS; S PHASE; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0032125559     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Li, L., and Cohen, S. N. tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells. Cell, 85: 319-329, 1996.
2. Maucuer, A., Camonis, J. H., and Sobel, A. Stathmin interaction with a putative kinase and coiled-coil-forming protein domains. Proc. Natl. Acad. Sci. USA, 92: 3100-3104, 1995.
3. Doye, V., Boutterin, M. C., and Sobel, A. Phosphorylation of stathmin and other proteins related to nerve growth factor-induced regulation of PC12 cells. J. Biol. Chem., 265: 11650-11655, 1990.
4. Marklund, U., Brattsand, G., Osterman, O., Ohisson, P. I., and Gullberg, M. Multiple signal transduction pathways induce phosphorylation of serine 16, 25, and 38 of oncoprotein 18 in T lymphocytes. J. Biol. Chem., 268: 25671-25680, 1993.
5. Zhong, Q., Chen, C-F., Chen, Y., Chen, P-L., and Lee, W-H. Identification of cellular TSG101 protein in multiple human breast cancer cell lines. Cancer Res., 57: 4225-4228, 1997.
6. Koonin, E. V., and Abagyan, R. TSG101 may be the prototype of a class of dominant negative ubiquitin regulators. Nat. Genet., 16: 330-331, 1997.
7. Ponting, C. P., Cai, Y-D., and Bork, P. The breast cancer gene product TSG101: a regulator of ubiquitination? J. Mol. Med., 75: 467-469, 1997.
8. Harlow, E., and Lane, D. Antibodies: A Laboratory Manual, pp. 139-243. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1988.
9. Chen, Y., Farmer, A. A., Chen, C-F., Jones, D. C., Chen, P-L., and Lee, W-H. BRCA1 is a 220-kDa nuclear phosphoprotein that is phosphorylated in a cell cycle-dependent manner. Cancer Res., 56: 3168-3172, 1996.
10. Chen, P-L., Riley, D. J., Chen-Kiang, S., and Lee, W-H. Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6. Proc. Natl. Acad. Sci. USA, 93: 465-469, 1996.
11. Chen, Y., Riley, D. J., Chen, P-L., and Lee, W-H. HEC, a novel nuclear protein rich in leucine heptad repeats specifically involved in mitosis. Mol. Cell. Biol., 17: 6049-6056, 1997.
12. 1 phase of the cell cycle. Cell, 67: 293-302, 1991.
13. Heim, R., Prasher, D. C., and Tsien, R. T. Wavelength mutations and posttranslational auto-oxidation of green fluorescent protein. Proc. Natl. Acad. Sci. USA, 91: 12501-12504, 1994.
14. Chen, P-L., Scully, P., Shew, J. Y., Wang, J. Y., and Lee, W-H. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cell differentiation. Cell, 58: 1193-1198, 1989.
15. Durfee, T., Mancini, M. A., Jones, D., Elledge, S. J., and Lee, W-H. The amino terminal region of the retinoblastoma gene product binds a novel nuclear matrix protein that localizes to RNA processing centers. J. Cell. Biol., 127: 609-622, 1994.
16. Xie, W., Li, L., and Cohen, S. N. Cell cycle-dependent subcellular localization of the TSG101 protein and mitotic and nuclear abnormalities associated with TSG101 deficiency. Proc. Natl. Acad. Sci. USA, 95: 1595-1600, 1998.
17. King, R. W., Desharies, R. J., Peters, J. M., and Kirschner, M. W. How proteolysis drives the cell cycle. Science (Washington DC), 274: 1652-1659, 1996.
18. Glotzer, M., Murray, A. W., and Kirschner, M. W. Cyclin is degraded by the ubiquitin pathway. Nature (Lond.), 349: 132-138, 1991.
19. Cohen-Fix, O., Peters, J. M., Kirschner, M. W., and Koshland, D. Anaphase initiation in Saccharomyces cerevisiae is controlled by the APC-dependent degradation of the anaphase inhibitor Pds1p. Genes Dev., 10: 3081-3093, 1996.
20. Holloway, S. L., Glotzer, M., King, R. W., and Murray, A. W. Anaphase is initiated by proteolysis rather than by the inactivation of maturation-promoting factor. Cell, 73: 1393-1402, 1993.
21. Mahajan, R., Delphin, C., Guan, T., Gerace, L., and Melchior, F. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell, 88: 97-107, 1997.
22. Schwarz, S. E., Matuschewski, K., Liakopoulos, D., Scheffner, M., and Jentsch, S. The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme. Proc. Natl. Acad. Sci. USA, 95: 560-564, 1998.
23. Muller, S., Matunis, M. J., and Dejean, A. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J., 17: 61-70, 1998.